Form 8-K - Current report:
SEC Accession No. 0000950170-25-040453
Filing Date
2025-03-17
Accepted
2025-03-17 17:01:18
Documents
11
Period of Report
2025-03-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgx-20250317.htm   iXBRL 8-K 47244
  Complete submission text file 0000950170-25-040453.txt   169107

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mgx-20250317.xsd EX-101.SCH 26951
13 EXTRACTED XBRL INSTANCE DOCUMENT mgx-20250317_htm.xml XML 5108
Mailing Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608
Business Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608 (510) 871-4880
Metagenomi, Inc. (Filer) CIK: 0001785279 (see all company filings)

EIN.: 813909017 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41949 | Film No.: 25745442
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)